Glenn P. Muir, Director at G1 Therapeutics, Inc. (GTHX), bought 120,969 shares at $15.00 ($300K) on 2017-05-22, disclosed to the SEC on 2017-05-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 100,969 | $0 | 0.0% |
| 2 | $15.00 | 20,000 | $300K | 100.0% |
| Total | $2.48 avg | 120,969 | $300K | 100% |
| Filing → |
| STIM | BUY | 2024-08-21 | $25K | — | Filing → |
| STIM | BUY | 2024-08-16 | $19K | — | Filing → |
| GTHX | BUY | 2020-11-19 | $675K | — | Filing → |